C6 NBD Lactosylceramide (d18:1/6:0) – 50 µg

Brand:
Cayman
CAS:
474943-04-9
Storage:
-20
UN-No:
Non-Hazardous - /

C6 NBD Lactosylceramide (d18:1/6:0) is a biologically active derivative of lactosylceramides (d18:1/acyl mixture) (Item No. 16983) that is tagged with a fluorescent C-6 nitrobenzoxadiazole (C-6 NBD; Item No. 18871) group.{37103} C6 NBD Lactosylceramide (d18:1/6:0) has been used to study the effects of P-glycoprotein inhibition in lactosylceramide metabolism-based therapeutics for the treatment of cancer. [Matreya, LLC. Catalog No. 1629]  

 

Out of stock

SKU: 22828 - Category:

Description

A fluorescently tagged sphingolipid; tagged with C-6 NBD; used to study effects of P-glycoprotein inhibition in ceramide metabolism-based therapeutics for treatment of cancer


Formal name: N-[(1S,2R,3E)-1-[[(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-hexanamide

Synonyms:  C6 NBD LacCer|C6 NBD Lactosylceramide|NBD LacCer(d18:1/6:0)|NBD Lactosylceramide (d18:1/6:0)

Molecular weight: 900

CAS: 474943-04-9

Purity: ≥98%

Formulation: A solid


Application|Enzyme Activity||Application|Fluorescence||Product Type|Biochemicals|Labeling & Detection|Enzyme Substrates||Product Type|Biochemicals|Labeling & Detection|Fluorescent Probes||Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Lipid Biochemistry|Sphingolipids